Academia
Researchers at the University of California, Los Angeles have identified a subclass of beta-amyloid that appears to be damaged by age and that appears to cause more damage in the brains of Alzheimer’s patients than so-called normal amyloid.
A study conducted at the University of Eastern Finland demonstrated that a recently described T-cell subset, so-called peripheral T helper cells, may have a role in the development of type 1 diabetes.
Research scientists representing Regenstrief Institute, Indiana University School of Medicine and IU Richard M. Fairbanks School of Public Health at IUPUI are joining – and in some cases leading – the global health conversation at the 17th World Congress of Medical and Health Informatics (MedInfo).
Susan Hickman, PhD, director of the Indiana University Center for Aging Research at Regenstrief Institute, and her colleagues nationwide are stressing the importance of including orders about artificial nutrition preferences on POLST forms.
The device is most likely to be used in optogenetics, where light is used to stimulate cellar activity. It may also have functionality for monitoring tissues and cells during medical procedures.
The researchers are currently optimizing the drug and similar drugs so they can advance to human clinical trials.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Researchers at Arizona State University are experimenting with a compound that might prevent Alzheimer’s and other neurodegenerative diseases, such as Parkinson’s disease, and potentially Down syndrome.
The researchers monitored the creation of neurons from human stem cells by identifying next-generation biomarkers called exosomes.
Carbon nanotubes are a type of nanomaterials made up of a two-dimensional lattice of carbon atoms. Researchers at Texas Heart Institute recently used bio-compatible nanotubes invented at Rice University to restore electrical function to damaged hearts.
PRESS RELEASES